Literature DB >> 16854563

White matter fractional anisotropy and outcome in schizophrenia.

Serge A Mitelman1, Randall E Newmark, Yuliya Torosjan, King-Wai Chu, Adam M Brickman, M Mehmet Haznedar, Erin A Hazlett, Cheuk Y Tang, Lina Shihabuddin, Monte S Buchsbaum.   

Abstract

OBJECTIVE: Disparate white matter fractional anisotropy (FA) findings have been reported in patients with schizophrenia in recent years. This may in part reflect heterogeneity of subjects in the studies, including differences in outcome and severity of the illness. We examined whether there is a relationship between white matter FA and outcome in patients with schizophrenia.
METHOD: Diffusion-tensor images were obtained in 41 normal subjects and 104 patients with schizophrenia, divided into good-outcome (n=51) and poor-outcome (Kraepelinian; n=53) subtypes based on their ability for self-care. White matter FA and its relationship to regional tissue volumes were evaluated across 40 individual Brodmann's areas using a semi-automated parcellation technique.
RESULTS: Overall white matter FA was lower in schizophrenia patients than normal subjects, with regional reductions in widespread temporoparietal and selected prefrontal white matter regions. In schizophrenia patients, lower regional white matter FA was associated with lower regional gray matter volumes. In comparison to normal subjects, overall white matter FA was reduced in patients with poor outcomes in both hemispheres, but to a lesser extent and only in the right hemisphere in good-outcome patients. Lower regional FA was associated with larger regional white matter volumes in good-outcome group.
CONCLUSIONS: Global FA reductions implicate white matter as tissue type in the pathophysiology of schizophrenia. In contrast to poor outcome, good outcome in schizophrenia patients may be associated with less extensive FA reductions, higher FA in regional frontal and cingulate white matter, and correlated increases in regional white matter volumes, particularly in the left hemisphere.

Entities:  

Mesh:

Year:  2006        PMID: 16854563     DOI: 10.1016/j.schres.2006.06.016

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  34 in total

1.  White matter volume abnormalities and associations with symptomatology in schizophrenia.

Authors:  Nikolaos Makris; Larry J Seidman; Todd Ahern; David N Kennedy; Verne S Caviness; Ming T Tsuang; Jill M Goldstein
Journal:  Psychiatry Res       Date:  2010-06-09       Impact factor: 3.222

Review 2.  Very poor outcome schizophrenia: clinical and neuroimaging aspects.

Authors:  Serge A Mitelman; Monte S Buchsbaum
Journal:  Int Rev Psychiatry       Date:  2007-08

Review 3.  Neuroimaging markers of antipsychotic treatment response in schizophrenia: An overview of magnetic resonance imaging studies.

Authors:  Goda Tarcijonas; Deepak K Sarpal
Journal:  Neurobiol Dis       Date:  2018-06-25       Impact factor: 5.996

4.  The course of neuropsychological performance and functional capacity in older patients with schizophrenia: influences of previous history of long-term institutional stay.

Authors:  Philip D Harvey; Abraham Reichenberg; Christopher R Bowie; Thomas L Patterson; Robert K Heaton
Journal:  Biol Psychiatry       Date:  2010-03-03       Impact factor: 13.382

5.  Brodmann area analysis of white matter anisotropy and age in schizophrenia.

Authors:  Jason S Schneiderman; Erin A Hazlett; King-Wai Chu; Jane Zhang; Chelain R Goodman; Randall E Newmark; Yuliya Torosjan; Emily L Canfield; Jonathan Entis; Vivian Mitropoulou; Cheuk Y Tang; Joseph Friedman; Monte S Buchsbaum
Journal:  Schizophr Res       Date:  2011-05-19       Impact factor: 4.939

6.  Corpus callosum size and diffusion tensor anisotropy in adolescents and adults with schizophrenia.

Authors:  Emily C Balevich; M Mehmet Haznedar; Eugene Wang; Randall E Newmark; Rachel Bloom; Jason S Schneiderman; Jonathan Aronowitz; Cheuk Y Tang; King-Wai Chu; William Byne; Monte S Buchsbaum; Erin A Hazlett
Journal:  Psychiatry Res       Date:  2015-01-08       Impact factor: 3.222

7.  White matter organization and neurocognitive performance variability in schizophrenia.

Authors:  David R Roalf; Kosha Ruparel; Ragini Verma; Mark A Elliott; Raquel E Gur; Ruben C Gur
Journal:  Schizophr Res       Date:  2012-11-11       Impact factor: 4.939

8.  Shared and distinct alterations of white matter tracts in remitted and nonremitted patients with schizophrenia.

Authors:  Jing-Ying Huang; Chih-Min Liu; Tzung-Jeng Hwang; Yu-Jen Chen; Yung-Chin Hsu; Hai-Gwo Hwu; Yi-Tin Lin; Ming-Hsien Hsieh; Chen-Chung Liu; Yi-Ling Chien; Wen-Yih Isaac Tseng
Journal:  Hum Brain Mapp       Date:  2018-01-28       Impact factor: 5.038

9.  A longitudinal study of the corpus callosum in chronic schizophrenia.

Authors:  Serge A Mitelman; Yekaterina K Nikiforova; Emily L Canfield; Erin A Hazlett; Adam M Brickman; Lina Shihabuddin; Monte S Buchsbaum
Journal:  Schizophr Res       Date:  2009-08-26       Impact factor: 4.939

10.  [Not Available].

Authors:  Serge A Mitelman; Emily L Canfield; Randall E Newmark; Adam M Brickman; Yuliya Torosjan; King-Wai Chu; Erin A Hazlett; M Mehmet Haznedar; Lina Shihabuddin; Monte S Buchsbaum
Journal:  Open Neuroimag J       Date:  2009-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.